Breast cancer - Changing role of the pathologist

Bahrain Medical Bulletin

Volumn 28, Issue 1, 2006, Pages 3-4

  Al Yusuf, Raja ^a  

^a SALMANIYA MEDICAL COMPLEX   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GENE PRODUCT; PROGESTERONE RECEPTOR; TRASTUZUMAB;

BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; DIAGNOSTIC VALUE; DNA SEQUENCE; EARLY DIAGNOSIS; EDITORIAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 33645282790     PISSN: 10128298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Tavassoli FA. Pathology of the Breast. Connecticut. Appleton & Lange. 1999:27-8, 51.
2. Haward R, Amir Z, Borrill C et al. Breast Cancer Teams: The Impact of Constitution, New Cancer Workload, and Methods of Operation on their Effectiveness. Br J Cancer 2003; 89:15-22.
3. Emens LA. Trastuzumab: Targeted Therapy for the Management of HER-2/neu-over expressing Metastatic Breast Cancer. Am J Ther 2005; 12:243-53.
4. Bilous M, Dowsett M, Hanna W, et al. Current Perspectives on HER2 Testing: A of National Testing Guidelines. Mod Pathol 2003; 16:173-82.
5. Pavelic K, Gall-Troselj K. Recent Advances in Molecular Genetics of Breast. J Mol Med 2001; 79:566-73.